LU GROUP IS THE HOME OF OMICS
Metabolomics combined with genetic approaches facilitate chemical biology studies with emphasis on delineating the pathogenesis of metabolic and infectious diseases, facilitating the therapeutic discovery of the selected small-molecule natural products and TCM formulae against above diseases, as well as promoting the discovery and development of novel small-molecule drugs.
Omics sciences driven translational research of metabolic/infectious diseases, and transfer the bench outcomes to the use in bedside in population context.
Lu Group resided in Shanghai Jiao Tong University where we launch the scheme of "Metabolomics 2.0", as Precision-Modified Metabolomics works for the future.
INSIGHT NEWS
Nov 18, 2016. Congratulations Dr. Ke Chen successfully secured her first Kid-Grant for Medicine-Engineering Collaboration from SJTU.
Nov 15, 2016. Prof. Lu was invited by Prof. Xiaojun Han to visit HIT and deliver a presentation.
Nov 8, 2016. Prof. Lu was invited by Prof. Huaili Zhou to visit SWJTU and deliver a scientific talk.
Oct 25, 2016. Prof. Lu was invited by Prof. Wenxia Zhou to deliver a talk at The Fourth Annal Meeting of China Pharmacological Society.
Aug 17, 2016. The Application of National Natural Science Foundation of China Grant has been successful ! Cheers !
Jun 30, 2016. Welcome Dr. Ke Chen to join our group as an Assistant Professor.
Jun 27, 2016. Congratulations Qiao and Qiang again, their co-first authored research paper collaborated with China Academy of Medical Sciences was accepted by Oncotarget.
Metabolomics Driven Metabolic Health
Website Copyright is Reserved for LU Group Only, Please Do not Disclose, Distribute and Copy Before You Receive the Official Authorization
